Showing results (1991-2000 of 2,010) with videos related to

Sort By:
Pageof 201
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Lower Airway Dysbiosis in NTM+ Bronchiectasis is Associated with NET-Predominant Severe PhenotypesShivani Singh, Fares Darawshy, Kirby Erlandson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Emanuele Marra, Fabio Palombo, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
BJS Open|July 10, 2024
Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensusRené Sotelo, Aref S Sayegh, Luis G Medina, et al.
Annals of Surgery|February 13, 2024
30-day Morbidity and Mortality after Cholecystectomy for Benign Gallbladder Disease (AMBROSE): A Prospective, International Collaborative Cohort StudyGeoffrey Yuet Mun Wong, Himanshu Wadhawan, Victor Roth Cardoso, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
Infection|October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupV Svicher, C Alteri, M Montano, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2013
[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]V Saglimbene, D D'Alonzo, M Ruospo, et al.
Human Mutation|October 10, 2019
Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1Magdalena Koczkowska, Tom Callens, Yunjia Chen, et al.
Pageof 201